New Jersey-based Dr Reddy's Laboratories Inc, a unit of the company, is recalling the affected lot due to the presence of one Tacrolimus 1 mg capsule co-mingled in a bottle containing and labeled as Tacrolimus 0.5 mg capsules, USFDA said in its latest Enforcement Report.
from Top Health News | Latest Health & Healthcare Industry Information and Updates: ET HealthWorld : ETHealthworld.com https://ift.tt/2OVmUPt
No comments:
Post a Comment